Showing results (1151-1160 of 2,915) with videos related to
Sort By:
Pageof 292
Cancer Gene Therapy|January 29, 2005
Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responsesHongxun Sang, Vladimir M Pisarev, Jennifer Chavez, et al.Cancer Gene Therapy|October 9, 2004
Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastasesArnaud Alves, Eric Vibert, Stephane Trajcevski, et al.Cancer Gene Therapy|October 23, 2004
Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TKSurren A Soghomonyan, Michael Doubrovin, Jeremy Pike, et al.Cancer Gene Therapy|October 23, 2004
Suicide gene therapy: conversion of ethanol to acetaldehyde mediated by human beta 2 alcohol dehydrogenasePhilip Savage, Pam Cowburn, Dahn Clemens, et al.Cancer Gene Therapy|October 12, 2004
Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic modelAlireza Biglari, Dominique Bataille, Ulrike Naumann, et al.Cancer Gene Therapy|September 9, 2004
Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapyDale C Slavin-Chiorini, Marta Catalfamo, Chie Kudo-Saito, et al.Cancer Gene Therapy|May 29, 2004
Sensitizing glioma cells to cisplatin by abrogating the p53 response with antisense oligonucleotidesKamal Datta, Preeti Shah, Tapasya Srivastava, et al.Cancer Gene Therapy|April 27, 2004
Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroidsLiliana M E Finocchiaro, Viviana F Bumaschny, Armando L Karara, et al.Cancer Gene Therapy|March 16, 2002
Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinomaNagy Habib, Hosny Salama, Ahmed Abd El Latif Abu Median, et al.Cancer Gene Therapy|March 16, 2002
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levelsChristoph Rochlitz, Brigitte Dreno, Peter Jantscheff, et al.Pageof 292